However, our patient‘s survival from FLC escape was only three months, while the median survival from FLC escape relapse was 27.7 months in IgG and IgA MM patients [2], illustrating a very aggressive relapse as FLC escape. This evidence concerns the gene CD79A and Miyoshi myopathy.